The US Food and Drug Administration has cleared Abbott's latest optical coherence tomography (OCT) imaging platform powered by its new Ultreon Software, the company has announced. The system is ...

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed, investigational system that aims to fracture hardened calcium within the ...